The clinical usefulness of spit-out method in house dust mite sublingual immunotherapy

被引：0
|
作者：
Sakaguchi, Y. [1 ]
Naoko, F. [1 ]
Hironaga, Y. [1 ]
Kyohei, T. [1 ]
Noriyuki, Y. [1 ]
Sakura, S. [1 ]
Ebisawa, M. [1 ]
机构：
[1] Sagamihara Natl Hosp, Sagamihara, Kanagawa, Japan
来源：
ALLERGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
001381
引用
收藏
页码：73 / 74
页数：2
相关论文
共 50 条
  • [41] Clinical relevance of house dust mite immunotherapy Reply
    Bergmann, Karl-Christian
    Demoly, Pascal
    Abiteboul, Kathy
    Zeldin, Robert K.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (01) : 288 - 289
  • [42] Steroid sparing effect of 300IR house dust mite sublingual immunotherapy tablet in house dust mite allergic rhinitis patients
    Demoly, P.
    Pfaar, O.
    Gevaert, P.
    Canonica, G. W.
    Casale, T.
    Scurati, S.
    Dolimier, E.
    ALLERGY, 2023, 78 : 217 - 218
  • [43] Nasal provocation testing for detection of house dust mite sensitisation with solutions prepared by dissolving the SQ house dust mite sublingual immunotherapy tablet
    Horn, A.
    ALLERGY, 2018, 73 : 399 - 399
  • [44] House dust mite sublingual immunotherapy tablet safety in adolescents with allergic rhinoconjunctivitis Worldwide clinical trial results
    Horn, Andreas
    Bernstein, David I.
    Okubo, Kimihiro
    Dalgaard, Terrie
    Hels, Ole
    Sorensen, Helle Frobose
    Henriksen, Marianne
    Azuma, Ryuji
    Mikler, Jan
    Nolte, Hendrik
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 130 (06) : 797 - +
  • [45] No Severe Anaphylaxis in Clinical Trials of House Dust Mite Sublingual Immunotherapy Tablet Using a Standardized Identification Algorithm
    Hulstroem, Veronica
    Gronskyte, Ruta
    Nolte, Hendrik
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB128 - AB128
  • [46] House dust mite sublingual immunotherapy is safe in patients with mild-to-moderate, persistent asthma: a clinical trial
    Devillier, P.
    Fadel, R.
    de Beaumont, O.
    ALLERGY, 2016, 71 (02) : 249 - 257
  • [47] Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma A Randomized Clinical Trial
    Virchow, J. Christian
    Backer, Vibeke
    Kuna, Piotr
    Prieto, Luis
    Nolte, Hendrik
    Villesen, Hanne Hedegaard
    Ljorring, Christian
    Riis, Bente
    de Blay, Frederic
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (16): : 1715 - 1725
  • [48] Clinical experience of sublingual immunotherapy to house dust mite in the regional allergy and immunology unit in Newcastle Upon Tyne
    Stroud, C.
    Green, T.
    Grix, O.
    Spickett, G. P.
    Bourne, H. C.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2015, 45 (02): : 501 - 501
  • [49] Consensus on the treatment of allergic asthma with sublingual house dust mite immunotherapy in the field of pneumology
    Plaza, Vicente
    Arnedillo, Aurelio
    Blanco-Aparicio, Marina
    Ignacio, Jose Maria
    Urrutia, Isabel
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2021, 15 (10) : 1245 - 1249
  • [50] Dual sublingual immunotherapy with Japanese Cedar Pollen droplets and House Dust Mite tablets
    Matsuoka, Tomokazu
    Igarashi, Satoshi
    Kuroda, Yuumi
    Fukano, Chiharu
    Natsui, Kensuke
    Doi-Ohashi, Katsuyo
    Masuyama, Keisuke
    ALLERGOLOGY INTERNATIONAL, 2019, 68 (04) : 533 - 535
12345